Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rajesh Malik currently holds 87,450 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rajesh Malik has been a net seller of GTHX stock. They have purchased $24.6K and sold $3.9M worth of shares.
Rajesh Malik's most recent insider trade was on Sep 18, 2024, when they sold 74,500 shares at $0.00 per share.
Rajesh Malik serves as Executive at G1 Therapeutics, Inc. (GTHX). They have executed 89 insider transactions totaling $4.0M over their tenure at the company.
Rajesh Malik holds the position of Executive at G1 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Rajesh Malik has shown a selling trading pattern, with $24.6K in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rajesh Malik was on Mar 2, 2021, when they sold $344.3K worth of GTHX shares. This transaction involved 15,000 shares at $22.95 per share.
Rajesh Malik currently owns 87,450 shares of G1 Therapeutics, Inc. (GTHX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rajesh Malik's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rajesh Malik has 89 Form 4 filings on record as an insider at G1 Therapeutics, Inc..
Set alerts for Rajesh Malik and 40,000+ other insiders.